Baxter CDMO BioPharma Solutions names Franco Negron as CEO ahead of proposed sale
Baxter’s CDMO arm, BioPharma Solutions, has announced a new CEO will take the reins following its proposed sale to private equity company Advent International and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.